INCANNEX HEALTHCARE LIMITED - Announcements

0.00%

4.1¢

Currently unlisted.

Incannex Healthcare Limited is an Australia-based clinical-stage pharmaceutical... Incannex Healthcare Limited is an Australia-based clinical-stage pharmaceutical development company. The Company is focused on developing medicinal cannabis pharmaceutical products and psychedelic medicine therapies for the treatment of generalized anxiety disorder (GAD), obstructive sleep apnea (OSA), traumatic brain injury (TBI)/concussion, lung inflammation, rheumatoid arthritis and inflammatory bowel disease. Its drug candidates include IHL-42X, IHL-216A and HL-675A. Its IHL-42X is a combination of acetazolamide and dronabinol for treatment of OSA. Its IHL-216A is a combination of isoflurane and cannabidiol (CBD) to prevent development of TBI/concussion. Its HL-675A comprises a combination of hydroxychloroquine and CBD for prevention and treatment of inflammatory lung conditions, rheumatoid arthritis and inflammatory bowel diseases. It is also investigating the use of psilocybin assisted psychotherapy to treat GAD.More

RCE'S BREAKTHROUGH

Recce Pharmaceuticals (ASX:RCE) accelerates commercialisation with positive Phase II results.

Announcements

Filter Results

All Price Sensitive Only

IHL	IHL-42X patent update & open label extension study approval	PRICE SENSITIVE	22/07/21	155.81KB	Share
IHL	Cleansing Notice and Appendix 2A - Options Exercise		21/07/21	277.63KB	Share
IHL	Trading Halt	PRICE SENSITIVE	20/07/21	200.44KB	Share
IHL	Incannex engages Procaps for production of IHL-675A	PRICE SENSITIVE	16/07/21	170.18KB	Share
IHL	Company Secretary Appointment/Resignation		07/07/21	132.22KB	Share
IHL	Diectors' Disclosures (4 x Appendix 3Y)		01/07/21	475KB	Share
IHL	Changes to Securities on Issue		01/07/21	273.06KB	Share
IHL	IHL-216A formulation and manufacturing appointment	PRICE SENSITIVE	21/06/21	172.04KB	Share
IHL	Escrow release		18/06/21	138.33KB	Share
IHL	Cleansing Notice and Appendix 2A		10/06/21	274.66KB	Share
IHL	Cleansing Notice and Apendix 2A - Options Exercise		21/05/21	319.53KB	Share
IHL	IHL-42X OSA Update	PRICE SENSITIVE	11/05/21	193.11KB	Share
IHL	Cleansing Notice and Appendix 2A - Options exercise		10/05/21	322.9KB	Share
IHL	Appendix 3Y - Peter Widdows		10/05/21	144.77KB	Share
IHL	Cleansing Notice and Appendix 2A - Options exercise		29/04/21	331.94KB	Share
IHL	Quarterly Activities Report - Mar21	PRICE SENSITIVE	29/04/21	406.92KB	Share
IHL	Positive FDA Pre-IND meeting guides IHL-675A development	PRICE SENSITIVE	22/04/21	186.96KB	Share
IHL	Cleansing Notice and Appendix 2A		26/03/21	325.45KB	Share
IHL	IHL-675A Pre-IND meeting with FDA update	PRICE SENSITIVE	25/03/21	153.84KB	Share
IHL	IHL-675A outperforms existing treatment for arthritis	PRICE SENSITIVE	16/03/21	499.43KB	Share
IHL	Trading Halt	PRICE SENSITIVE	12/03/21	205.55KB	Share
IHL	IHL-216A to be assessed in NFL model of concussion	PRICE SENSITIVE	11/03/21	185.15KB	Share
IHL	Cleansing Notice and Appendix 2A		08/03/21	326.08KB	Share
IHL	Change in Director's Interest		26/02/21	187.35KB	Share
IHL	Appendix 4D correction	PRICE SENSITIVE	26/02/21	141.19KB	Share
IHL	Cleansing Notice and Appendix 2A		26/02/21	318.89KB	Share
IHL	Appendix 3G		26/02/21	107.46KB	Share
IHL	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/21	1.03MB	Share
IHL	Proposed issue of Securities - IHL		22/02/21	27.61KB	Share
IHL	IHL-675A in vivo results for Inflammatory Bowel Disease	PRICE SENSITIVE	16/02/21	384.42KB	Share
IHL	Trading Halt	PRICE SENSITIVE	12/02/21	201.85KB	Share
IHL	IHL appoints EAS Advisors LLC to facilitate US listing	PRICE SENSITIVE	11/02/21	152.34KB	Share
IHL	IHL-675A in vivo results for COPD and asthma	PRICE SENSITIVE	04/02/21	290.02KB	Share
IHL	Quarterly Activities Report - Dec 2020	PRICE SENSITIVE	29/01/21	439.5KB	Share
IHL	Cleansing Notice and Appendix 2A		28/01/21	325.86KB	Share
IHL	Incannex AGM Presentation	PRICE SENSITIVE	25/01/21	2.66MB	Share
IHL	AGM CEO Address to Shareholders		25/01/21	151.21KB	Share
IHL	AGM Poll Results		25/01/21	571.49KB	Share
IHL	Cleansing Notice and Appendix 2A		20/01/21	321.94KB	Share
IHL	Cleansing Notice and Appendix 2A		04/01/21	322.93KB	Share
IHL	Cleansing Notice and Appendix 2A		31/12/20	322.82KB	Share
IHL	Cleansing Notice and Appendix 2A		24/12/20	832.89KB	Share
IHL	First patients recruited for IHL-42X (OSA) trial	PRICE SENSITIVE	21/12/20	162.33KB	Share
IHL	Director's interest - Appendix 3Y		17/12/20	187.88KB	Share
IHL	Cleansing Notice & Appendix 2A		17/12/20	340.85KB	Share
IHL	Notice of Annual General Meeting/Proxy Form		17/12/20	764.9KB	Share
IHL	Positive results from IHL-216A TBI/concussion study	PRICE SENSITIVE	15/12/20	453.78KB	Share
IHL	IHL initiates psilocybin clinical trial for anxiety disorder	PRICE SENSITIVE	08/12/20	1.25MB	Share
IHL	Appendix 3Y		04/12/20	188.39KB	Share
IHL	Cleansing Notice and Appendix 2A		04/12/20	355.98KB	Share
IHL	Trading Halt	PRICE SENSITIVE	04/12/20	202.56KB	Share
IHL	Positive IHL-675A in vivo results and FDA Pathway	PRICE SENSITIVE	23/11/20	439.93KB	Share
IHL	Appendix 3G - issue of options		20/11/20	109.44KB	Share
IHL	Trading Halt	PRICE SENSITIVE	19/11/20	204.17KB	Share
IHL	Proposed issue of Securities - IHL		18/11/20	29.63KB	Share
IHL	Canary Capital Appointed as Corporate Advisor		18/11/20	135.86KB	Share
IHL	Strong anti-inflammatory action from IHL-675A	PRICE SENSITIVE	05/11/20	355.62KB	Share
IHL	Trading Halt	PRICE SENSITIVE	03/11/20	206.62KB	Share
IHL	Trading Halt	PRICE SENSITIVE	03/11/20	206.63KB	Share
IHL	Sep20 Quarterly Activities update and Appendix 4C	PRICE SENSITIVE	22/10/20	439.62KB	Share
IHL	Appendix 3Y		19/10/20	197.24KB	Share
IHL	Cleansing Notice		19/10/20	140.74KB	Share
IHL	Appendix 2A		19/10/20	103.19KB	Share
IHL	Record Sales for September Quarter	PRICE SENSITIVE	06/10/20	184.21KB	Share
IHL	Appendix 3Y x 3		05/10/20	856.84KB	Share
IHL	Cleansing Notice		02/10/20	132.11KB	Share
IHL	Completion of IHLOB Exercise Program (incl. Appendix 2As)	PRICE SENSITIVE	02/10/20	284.17KB	Share
IHL	Appendix 3G		02/10/20	101.74KB	Share
IHL	Proposed issue of Securities - IHL		02/10/20	24.65KB	Share
IHL	Proposed issue of Securities - IHL		02/10/20	24.8KB	Share
IHL	Ceasing to be a substantial holder		01/10/20	1.11MB	Share
IHL	Exercise of Options		25/09/20	119.31KB	Share
IHL	IHL Receives Ethics Approval for Phase 2 OSA Trial	PRICE SENSITIVE	24/09/20	159.67KB	Share
IHL	IHL Appoints Dr Paul Liknaitzky to Advisory Board		22/09/20	136.26KB	Share
IHL	Options Exercise		17/09/20	119.25KB	Share
IHL	Options exercise		11/09/20	119.22KB	Share
IHL	Options exercise		04/09/20	119.21KB	Share
IHL	Options Exercise		28/08/20	119.27KB	Share
IHL	Positive Results from IHL-675A (ARDS) in vitro Study	PRICE SENSITIVE	26/08/20	301.35KB	Share
IHL	Exercise of Options		21/08/20	119.96KB	Share
IHL	Appendix 4G - Corporate Governance Report		14/08/20	195.73KB	Share
IHL	Annual Report		14/08/20	1005.72KB	Share
IHL	Exercise of Options		14/08/20	119.76KB	Share
IHL	Preliminary Final Report	PRICE SENSITIVE	14/08/20	1.46MB	Share
IHL	Letter to Optionholders		10/08/20	481.83KB	Share
IHL	Exercise of Options		07/08/20	119.68KB	Share
IHL	Options Exercise		31/07/20	119.79KB	Share
IHL	Quarterly Activities Report and Appendix 4C	PRICE SENSITIVE	29/07/20	438.36KB	Share
IHL	Exercise of Options		24/07/20	119.88KB	Share
IHL	IHL commences IHL-216A TBI / Concussion Animal Study	PRICE SENSITIVE	23/07/20	153.78KB	Share
IHL	Options exercise		17/07/20	119.93KB	Share
IHL	Appendix 3Y		17/07/20	146.88KB	Share
IHL	Positive Results from IHL-675 (ARDS) animal study	PRICE SENSITIVE	17/07/20	317.91KB	Share
IHL	Trading Halt	PRICE SENSITIVE	15/07/20	206.94KB	Share
IHL	Options exercise		14/07/20	119.92KB	Share
IHL	Clinical Update on IHL-42X for Obstructive Sleep Apnoea	PRICE SENSITIVE	09/07/20	232.27KB	Share
IHL	Change in Director's Interest x 2		06/07/20	267.27KB	Share
IHL	Change in Director's Notices x 2		06/07/20	211.36KB	Share
IHL	Exercise of Options		02/07/20	119.78KB	Share
IHL	Record Sales for June Quarter	PRICE SENSITIVE	02/07/20	177.63KB	Share

IHL IHL-42X patent update & open label extension study approval
22/07/21	PRICE SENSITIVE	155.81KB	Share
IHL Cleansing Notice and Appendix 2A - Options Exercise
21/07/21		277.63KB	Share
IHL Trading Halt
20/07/21	PRICE SENSITIVE	200.44KB	Share
IHL Incannex engages Procaps for production of IHL-675A
16/07/21	PRICE SENSITIVE	170.18KB	Share
IHL Company Secretary Appointment/Resignation
07/07/21		132.22KB	Share
IHL Diectors' Disclosures (4 x Appendix 3Y)
01/07/21		475KB	Share
IHL Changes to Securities on Issue
01/07/21		273.06KB	Share
IHL IHL-216A formulation and manufacturing appointment
21/06/21	PRICE SENSITIVE	172.04KB	Share
IHL Escrow release
18/06/21		138.33KB	Share
IHL Cleansing Notice and Appendix 2A
10/06/21		274.66KB	Share
IHL Cleansing Notice and Apendix 2A - Options Exercise
21/05/21		319.53KB	Share
IHL IHL-42X OSA Update
11/05/21	PRICE SENSITIVE	193.11KB	Share
IHL Cleansing Notice and Appendix 2A - Options exercise
10/05/21		322.9KB	Share
IHL Appendix 3Y - Peter Widdows
10/05/21		144.77KB	Share
IHL Cleansing Notice and Appendix 2A - Options exercise
29/04/21		331.94KB	Share
IHL Quarterly Activities Report - Mar21
29/04/21	PRICE SENSITIVE	406.92KB	Share
IHL Positive FDA Pre-IND meeting guides IHL-675A development
22/04/21	PRICE SENSITIVE	186.96KB	Share
IHL Cleansing Notice and Appendix 2A
26/03/21		325.45KB	Share
IHL IHL-675A Pre-IND meeting with FDA update
25/03/21	PRICE SENSITIVE	153.84KB	Share
IHL IHL-675A outperforms existing treatment for arthritis
16/03/21	PRICE SENSITIVE	499.43KB	Share
IHL Trading Halt
12/03/21	PRICE SENSITIVE	205.55KB	Share
IHL IHL-216A to be assessed in NFL model of concussion
11/03/21	PRICE SENSITIVE	185.15KB	Share
IHL Cleansing Notice and Appendix 2A
08/03/21		326.08KB	Share
IHL Change in Director's Interest
26/02/21		187.35KB	Share
IHL Appendix 4D correction
26/02/21	PRICE SENSITIVE	141.19KB	Share
IHL Cleansing Notice and Appendix 2A
26/02/21		318.89KB	Share
IHL Appendix 3G
26/02/21		107.46KB	Share
IHL Half Yearly Report and Accounts
26/02/21	PRICE SENSITIVE	1.03MB	Share
IHL Proposed issue of Securities - IHL
22/02/21		27.61KB	Share
IHL IHL-675A in vivo results for Inflammatory Bowel Disease
16/02/21	PRICE SENSITIVE	384.42KB	Share
IHL Trading Halt
12/02/21	PRICE SENSITIVE	201.85KB	Share
IHL IHL appoints EAS Advisors LLC to facilitate US listing
11/02/21	PRICE SENSITIVE	152.34KB	Share
IHL IHL-675A in vivo results for COPD and asthma
04/02/21	PRICE SENSITIVE	290.02KB	Share
IHL Quarterly Activities Report - Dec 2020
29/01/21	PRICE SENSITIVE	439.5KB	Share
IHL Cleansing Notice and Appendix 2A
28/01/21		325.86KB	Share
IHL Incannex AGM Presentation
25/01/21	PRICE SENSITIVE	2.66MB	Share
IHL AGM CEO Address to Shareholders
25/01/21		151.21KB	Share
IHL AGM Poll Results
25/01/21		571.49KB	Share
IHL Cleansing Notice and Appendix 2A
20/01/21		321.94KB	Share
IHL Cleansing Notice and Appendix 2A
04/01/21		322.93KB	Share
IHL Cleansing Notice and Appendix 2A
31/12/20		322.82KB	Share
IHL Cleansing Notice and Appendix 2A
24/12/20		832.89KB	Share
IHL First patients recruited for IHL-42X (OSA) trial
21/12/20	PRICE SENSITIVE	162.33KB	Share
IHL Director's interest - Appendix 3Y
17/12/20		187.88KB	Share
IHL Cleansing Notice & Appendix 2A
17/12/20		340.85KB	Share
IHL Notice of Annual General Meeting/Proxy Form
17/12/20		764.9KB	Share
IHL Positive results from IHL-216A TBI/concussion study
15/12/20	PRICE SENSITIVE	453.78KB	Share
IHL IHL initiates psilocybin clinical trial for anxiety disorder
08/12/20	PRICE SENSITIVE	1.25MB	Share
IHL Appendix 3Y
04/12/20		188.39KB	Share
IHL Cleansing Notice and Appendix 2A
04/12/20		355.98KB	Share
IHL Trading Halt
04/12/20	PRICE SENSITIVE	202.56KB	Share
IHL Positive IHL-675A in vivo results and FDA Pathway
23/11/20	PRICE SENSITIVE	439.93KB	Share
IHL Appendix 3G - issue of options
20/11/20		109.44KB	Share
IHL Trading Halt
19/11/20	PRICE SENSITIVE	204.17KB	Share
IHL Proposed issue of Securities - IHL
18/11/20		29.63KB	Share
IHL Canary Capital Appointed as Corporate Advisor
18/11/20		135.86KB	Share
IHL Strong anti-inflammatory action from IHL-675A
05/11/20	PRICE SENSITIVE	355.62KB	Share
IHL Trading Halt
03/11/20	PRICE SENSITIVE	206.62KB	Share
IHL Trading Halt
03/11/20	PRICE SENSITIVE	206.63KB	Share
IHL Sep20 Quarterly Activities update and Appendix 4C
22/10/20	PRICE SENSITIVE	439.62KB	Share
IHL Appendix 3Y
19/10/20		197.24KB	Share
IHL Cleansing Notice
19/10/20		140.74KB	Share
IHL Appendix 2A
19/10/20		103.19KB	Share
IHL Record Sales for September Quarter
06/10/20	PRICE SENSITIVE	184.21KB	Share
IHL Appendix 3Y x 3
05/10/20		856.84KB	Share
IHL Cleansing Notice
02/10/20		132.11KB	Share
IHL Completion of IHLOB Exercise Program (incl. Appendix 2As)
02/10/20	PRICE SENSITIVE	284.17KB	Share
IHL Appendix 3G
02/10/20		101.74KB	Share
IHL Proposed issue of Securities - IHL
02/10/20		24.65KB	Share
IHL Proposed issue of Securities - IHL
02/10/20		24.8KB	Share
IHL Ceasing to be a substantial holder
01/10/20		1.11MB	Share
IHL Exercise of Options
25/09/20		119.31KB	Share
IHL IHL Receives Ethics Approval for Phase 2 OSA Trial
24/09/20	PRICE SENSITIVE	159.67KB	Share
IHL IHL Appoints Dr Paul Liknaitzky to Advisory Board
22/09/20		136.26KB	Share
IHL Options Exercise
17/09/20		119.25KB	Share
IHL Options exercise
11/09/20		119.22KB	Share
IHL Options exercise
04/09/20		119.21KB	Share
IHL Options Exercise
28/08/20		119.27KB	Share
IHL Positive Results from IHL-675A (ARDS) in vitro Study
26/08/20	PRICE SENSITIVE	301.35KB	Share
IHL Exercise of Options
21/08/20		119.96KB	Share
IHL Appendix 4G - Corporate Governance Report
14/08/20		195.73KB	Share
IHL Annual Report
14/08/20		1005.72KB	Share
IHL Exercise of Options
14/08/20		119.76KB	Share
IHL Preliminary Final Report
14/08/20	PRICE SENSITIVE	1.46MB	Share
IHL Letter to Optionholders
10/08/20		481.83KB	Share
IHL Exercise of Options
07/08/20		119.68KB	Share
IHL Options Exercise
31/07/20		119.79KB	Share
IHL Quarterly Activities Report and Appendix 4C
29/07/20	PRICE SENSITIVE	438.36KB	Share
IHL Exercise of Options
24/07/20		119.88KB	Share
IHL IHL commences IHL-216A TBI / Concussion Animal Study
23/07/20	PRICE SENSITIVE	153.78KB	Share
IHL Options exercise
17/07/20		119.93KB	Share
IHL Appendix 3Y
17/07/20		146.88KB	Share
IHL Positive Results from IHL-675 (ARDS) animal study
17/07/20	PRICE SENSITIVE	317.91KB	Share
IHL Trading Halt
15/07/20	PRICE SENSITIVE	206.94KB	Share
IHL Options exercise
14/07/20		119.92KB	Share
IHL Clinical Update on IHL-42X for Obstructive Sleep Apnoea
09/07/20	PRICE SENSITIVE	232.27KB	Share
IHL Change in Director's Interest x 2
06/07/20		267.27KB	Share
IHL Change in Director's Notices x 2
06/07/20		211.36KB	Share
IHL Exercise of Options
02/07/20		119.78KB	Share
IHL Record Sales for June Quarter
02/07/20	PRICE SENSITIVE	177.63KB	Share

REFRESH

First 2 3 4 5

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

INCANNEX HEALTHCARE LIMITED - Announcements

Announcements

Top Stories